Dr. Kewalramani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Mall Rd
# Lahey
Burlington, MA 01805Phone+1 781-744-8400Fax+1 781-744-5245
Summary
- Dr. Tarun Kewalramani is a hematologist in Burlington, MA and is affiliated with Lahey Hospital & Medical Center, Burlington. He received his medical degree from McGaw Medical Center of Northwestern University and has been in practice 22 years.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- Boston University Medical CenterResidency, Internal Medicine, 1995 - 1998
- Northwestern University The Feinberg School of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 1997 - 2026
- MA State Medical License 1995 - 2024
- NY State Medical License 1998 - 2009
- American Board of Internal Medicine Hematology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
Clinical Trials
- Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma Start of enrollment: 2003 Jan 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- 95 citationsProgressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's l...Tarun Kewalramani, Stephen D. Nimer, Andrew D. Zelenetz, S Malhotra, Jing Qin
Bone Marrow Transplantation. 2003-10-01 - 335 citationsAmerican Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy ProtectantsMartee L. Hensley, Karen L. Hagerty, Tarun Kewalramani, Daniel M. Green, Neal J. Meropol
Journal of Clinical Oncology. 2009-01-01 - 299 citationsRituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer, Carol S. Portlock, David J. Straus
Blood. 2004-05-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: